Is a complete WSE/MDB research report available?

No complete published report is available for wse/MDB (WSE/MDB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

WSE/MDB (WSE/MDB)

Warsaw Stock Exchange: WSE/MDB · PLN

PLN 0.39

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first WSE/MDB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	26.5M
Revenue (ttm)	43.9K
Net income (ttm)	-2.1M
EPS (ttm)	-PLN 0.03
Shares out	68M
Volume	111
Beta	0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 43.9K
Net income (ttm): -2.1M
EPS (ttm): -PLN 0.03
Market cap: 26.5M

All WSE/MDB indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

PLN

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	7.12
Employees Change	-10.88%
Employees Change Percent	-60.44
Enterprise value	PLN 30.4M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology & Medical Research
Last refreshed	2026-08-02
Market cap	PLN 26.5M
Price	PLN 0.39
Price currency	PLN
Rev Per Employee	6,271.43x
Sector	Healthcare
Sector PE	34.5
Sector PE Fwd	27.3
Sic	8731
Symbol	wse/MDB
Website	https://medicofarmabiotech.pl

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.84%
FCF yield	-3.55%
P/B ratio	5.19x
P/S ratio	603.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,005.43%
EBITDA Margin	-455.3%
Gross Profit	PLN -969,115
Net Income	PLN -2.1M
Pretax Margin	-4,736.04%
Profit Per Employee	PLN -297,018
ROA	-6.83
Roa5y	-6.92
ROCE	-30.72
ROE	-36.93
Roe5y	-22.14
ROIC	-16.84
Roic5y	-15.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.68%
Cagr15y	-4.68%
Cagr1y	27.89%
Cagr3y	-34.76%
Cagr5y	-33.06%
Revenue Growth	-90.55x
Revenue Growth Q	-67.86x
Revenue Growth3 Y	-68.75x
Revenue Growth5 Y	-57.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 0
Assets	PLN 13.8M
Cash	PLN 1,929
Current Assets	PLN 4.1M
Current Liabilities	PLN 4.6M
Debt	PLN 3.9M
Debt Equity	PLN 0.77
Debt FCF	PLN -4.16
Equity	PLN 5.1M
Interest Coverage	-4.57
Liabilities	PLN 8.7M
Long Term Assets	PLN 9.7M
Long Term Liabilities	PLN 4.1M
Net Cash	PLN -3.9M
Net Cash By Market Cap	PLN -14.74
Net Debt Equity	PLN 0.76
Tangible Book Value	PLN 5.1M
Tangible Book Value Per Share	PLN 0.07
WACC	9.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.89
Net Working Capital	PLN -525,461
Quick ratio	0.89
Working Capital	PLN -523,532
Working Capital Turnover	PLN -0.07

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-38.1%
1Y total return	27.87%
200-day SMA	0.47
3Y total return	-72.24%
50-day SMA	0.43
50-day SMA vs 200-day SMA	50under200
5Y total return	-86.55%
All Time High	8.5
All Time High Change	-95.41%
All Time High Date	2020-11-13
All Time Low	0.18
All Time Low Change	116.67%
All Time Low Date	2018-12-20
ATR	0.02
Beta	0.84
Beta1y	1.49
Beta2y	1
Ch YTD	-2.26
High	0.39
High52	1.4
High52 Date	2025-09-11
High52ch	-72.14%
Low	0.39
Low52	0.28
Low52 Date	2025-08-04
Low52ch	39.29%
Ma50ch	-9.81%
Price vs 200-day SMA	-17.76%
RSI	35.5
RSI Monthly	41.85
RSI Weekly	39.18
Sharpe ratio	0.63x
Sortino ratio	2.47
Tr YTD	-2.26
Tr15y	-51.25%
Tr1m	-10.55%
Tr1w	-3.94%
Tr3m	-17.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN -1.5M
Operating margin	-3,529.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,862,910%
Net Borrowing	940,400
Shares Out	67,978,300
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	12,654.6x
Bv Per Share	0.08
Ch10y	-38.1
Ch15y	-51.25
Ch1m	-10.55
Ch1w	-3.94
Ch1y	27.87
Ch3m	-17.72
Ch3y	-72.24
Ch5y	-86.55
Ch6m	-16.67
Change	0%
Change From Open	0
Close	0.39
Days Gap	0
Depreciation Amortization	1,492,833
Dollar Volume	43.29
Earnings Date	2026-08-11
EBIT	PLN -2.8M
EBITDA	PLN -1.3M
EPS	PLN -0.03
F Score	2
FCF	PLN -940,209
FCF EV Yield	-3.09x
FCF Per Share	PLN -0.01
Financing CF	940,400
Fiscal Year End	December
Founded	2,001
Is Primary Listing	1
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2011-11-08
Last Split Type	Reverse
Ma150	0.45
Ma150ch	-14.23%
Ma20	0.41
Ma20ch	-4.34%
Net CF	191
Next Earnings Date	2026-08-11
Open	0.39
Ppne	8,663,346
Price Date	2026-07-31
Ptbv Ratio	5.22
Relative Volume	0.01x
Revenue	43,900x
Tr6m	-16.67%
Volume	111
Z Score	0.53

WSE/MDB (WSE/MDB)

Coverage state: Market snapshot only — no published research

Generate the first WSE/MDB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · WSE/MDB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All WSE/MDB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on WSE/MDB

Frequently asked questions